Trial intelligence / Profile preview

Real-world study of Weichang'an pill for rotavirus enteritis in children

ChiCTR2000031488Phase 4Not yet recruiting

Sponsor
Central Hospital Affiliated to Shandong First Medical University
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Weichang'an in rotaviral diarrhea, sponsored by Central Hospital Affiliated to Shandong First Medical University. Primary endpoints: Clinical efficacy of Weichang'an pill in rotavirus enteritis and Safety of Weichang'an pill in real-world use. Planned start Oct 2019; status: not yet recruiting.

02

Drugs

Weichang'an
03

Conditions

rotaviral diarrhea

Beyond the preview

Go deeper on ChiCTR2000031488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call